| Atellica IM CA 19-9 IIK253528 · NIG | Siemens Healthcare Diagnostics, Inc. | 510(k) | Aug 10, 2026FDA decision date |
| Atellica IM CA 19-9 (50 Test)-In vitro diagnostic use in the quantitative measurement of the CA 19-9 tumor-associated antigen in human serum usin…Z-3100-2024 · NIG | Siemens Healthcare Diagnostics, Inc. | Recall | Sep 11, 2024FDA classification date |
| Atellica IM CA 19-9 (250 Test)- In vitro diagnostic use in the quantitative measurement of the CA 19-9 tumor-associated antigen in human serum us…Z-3101-2024 · NIG | Siemens Healthcare Diagnostics, Inc. | Recall | Sep 11, 2024FDA classification date |
| Atellica IM CA 19-9 (250 Test - REF)-In vitro diagnostic use in the quantitative measurement of the CA 19-9 tumor-associated antigen in human ser…Z-3102-2024 · NIG | Siemens Healthcare Diagnostics, Inc. | Recall | Sep 11, 2024FDA classification date |
| ADVIA Centaur CA 19-9 (50 Test)-In vitro diagnostic use in the quantitative measurement of the CA 19-9 tumor-associated antigen in human serum us…Z-3103-2024 · NIG | Siemens Healthcare Diagnostics, Inc. | Recall | Sep 11, 2024FDA classification date |
| ADVIA Centaur CA 19-9 (250 Test)-In vitro diagnostic use in the quantitative measurement of the CA 19-9 tumor-associated antigen in human serum u…Z-3104-2024 · NIG | Siemens Healthcare Diagnostics, Inc. | Recall | Sep 11, 2024FDA classification date |
| VITROS Immunodiagnostic Products CA 19-9TM Reagent PackK231525 · NIG | Ortho Clinical Diagnostics | 510(k) | Aug 9, 2023FDA decision date |
| Beckman Coulter ACCESS Immunoassay Systems, Access GI Monitor Cancer Antigen 19-9, REF 387687 ( UDI: 15099590231842) the Access Family of Immuno…Z-2241-2020 · NIG | Beckman Coulter Inc. | Recall | Jun 2, 2020FDA classification date |
| Lumipulse G CA19-9-NK200997 · NIG | Fujirebio Diagnostics,Inc. | 510(k) | May 14, 2020FDA decision date |
| Elecsys CA 19-9, Cat. No. 07027028190 - Product Usage: the product is an immunoassay for monitoring and management of pancreatic cancerZ-1444-2020 · NIG | Roche Diagnostics Operations, Inc. | Recall | Mar 5, 2020FDA classification date |
| Lumpipulse G CA19-9-NK191973 · NIG | Fujirebio Dianostics, Inc. | 510(k) | Oct 22, 2019FDA decision date |
| ST-AIA PACK CA 19-9; Part Number: 025271
Assay, Tumor MarkerZ-2069-2018 · NIG | Tosoh Bioscience Inc | Recall | Jun 5, 2018FDA record creation date |
| Access System-GI Monitor (CA19-9), A83873D, Catalog No. 387687Z-2638-2017 · NIG | Beckman Coulter Inc. | Recall | Jun 28, 2017FDA record creation date |
| ADVIA Centaur CA 19-9 Assay (50 test kit)-for use, with the ADVIA Centaur and ADVIA Centaur XP, ADVIA Centaur XPT and ADVIA Centaur CP systems.
…Z-0612-2017 · NIG | Siemens Healthcare Diagnostics, Inc | Recall | Nov 17, 2016FDA record creation date |
| ADVIA Centaur CA 19-9 Assay (250 test kit)-for use,with the ADVIA Centaur and ADVIA Centaur XP, ADVIA Centaur XPT and ADVIA Centaur CP systems.
…Z-0613-2017 · NIG | Siemens Healthcare Diagnostics, Inc | Recall | Nov 17, 2016FDA record creation date |
| VITROS Immunodiagnostic Products CA 19-9 Calibrators and Reagent Packs, Lot 1320
VITROS CA 19-9 Reagent Packs are used on VITROS ECi/ECiQ Immu…Z-2183-2014 · NIG | ORTHO-CLINICAL DIAGNOSTICS | Recall | Aug 11, 2014FDA classification date |
| Siemens Healthcare ADVIA Centaur CA 19-9
250 Test 10491244
50 Test 10491379
Intended Use The ADVIA Centaur CA 19-9 Assay is an in vitro immunoa…Z-0508-2013 · NIG | Siemens Healthcare Diagnostics, Inc | Recall | Dec 11, 2012FDA classification date |
| ARCHITECT CA 19-9XR Reagent Kit; ARCHITECT CA 19-9 Reagent Kit, list 291-20 (4 x 100 tests), 2K91-25 and 2K91-27 (1 x 100 tests);
Product U…Z-1904-2012 · NIG | Abbott Laboratories | Recall | Jun 29, 2012FDA classification date |
| ADVIA Centaur CA19-9 Assay
Cat. Nos.
123521 (03481938) - 250 Test kit w/o Calibrators
123519 (04612750) - 50 Test kit w/o Calibrators
10491244 - …Z-0489-2012 · NIG | Siemens Healthcare Diagnostics, Inc | Recall | Jan 11, 2012FDA classification date |
| DIMENSION VISTA LOCI CA 19-9 FLEX REAGENT CARTRIDGE, AND DIMENSION LOCI7 CALIBRATOR WITH MODEL(S) K6457, AND KC604K100375 · NIG | Siemens Healthcare Diagnostics, Inc. | 510(k) | Apr 6, 2011FDA decision date |
| CA19-9 ELISA Kit.
BioCheck, Foster City, CA 9440.
Quantitative determination of AFP concentration in human serum.Z-1630-2011 · NIG | BioCheck Inc | Recall | Mar 11, 2011FDA classification date |
| VITROS CA 19-9K052889 · NIG | Fujirebio Diagnostics,Inc. | 510(k) | Dec 20, 2005FDA decision date |
| ARCHITECT CA 19-9XR ASSAYK052000 · NIG | Fujirebio Diagnostics,Inc. | 510(k) | Oct 25, 2005FDA decision date |
| TOSOH brand AIA-600 II Enzyme Immunoassay Analyzer; Software version 3.12, Catalog Numbers 019359, 019400; Model 019400, Smart MediaZ-0218-05 · NIG | Tosoh Bioscience, Inc. | Recall | Nov 30, 2004FDA classification date |
| Tosoh brand AIA-PACK CA 19-9 Test Cup Set used in TOSOH AIA Immunoassay Analyzers, A pack contains 10 trays of 20 test cups, Catalog #: 020271, F…Z-0197-05 · NIG | Tosoh Bioscience, Inc. | Recall | Nov 16, 2004FDA classification date |